Cannabics Pharmaceuticals Inc. (CNBX) Gains Foothold in Europe
Cannabics Pharmaceuticals is an emerging pharmaceutical development company whose flagship product is Cannabics SR, a medical cannabis capsule specifically designed as a palliative care treatment for cancer patients. The company’s proprietary SR technology provides ten to twelve hours of steady-state, beneficial therapeutic effects and, consequently, allows for a convenient oral, once-per-day dosing regimen for patients. Cannabics has been preparing to launch its line of SR products in eligible states of the US and EU markets under existing medical cannabis regulatory policies. The company is also now in its final stage of planning a series of formal clinical studies intended to…